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exandroupolis, Greece.Summary Pulmonary alveolar proteinosis (PAP) is a rare, heterogeneous diffuse
lung disease in childhood. We report a case of an asymptomatic 13-year old girl with
PAP. She had radiolographic findings suggesting the diagnosis, which was confirmed
by the ‘‘milky’’ bronchoalveolar lavage fluid and the histology of transbronchial
biopsy. Total lung lavage was performed by flexible fiberoptic bronchoscope under
local anesthesia with success. This is the first reported case of a PAP in a child that
was treated by being awake during bronchoscopy. After one-year of follow-up, the
patient remains free of symptoms.
& 2006 Elsevier Ltd. All rights reserved.Introduction
Pulmonary alveolar proteinosis (PAP) is a rare
disease. This disease is characterized by an
accumulation of amorphous lipoproteinaceous ma-
terial, diastase resistant, within the alveolar
spaces, stained positively by periodic acid Shiff.Elsevier Ltd. All rights reserve
0 2551075096
.gr (M.E. Froudarakis).
f Alexandroupolis, Demo-
Hospital of Alexandrou-This results in a progressive impairment of gas
exchange.1,2 PAP was first described by Rosen et al.
in 1958 in adults, however, is rare in children.3 The
clinical presentation of the disease is variable. PAP
more likely represents a clinical syndrome occur-
ring in three distinct categories: congenital, sec-
ondary and idiopathic or acquired. Although some
recent papers reported the efficacy of GM-CSF in
PAP, the generally accepted treatment of PAP is
total lung lavage (TLL) performed by rigid broncho-
scopy under general anesthesia, selective intuba-
tion and mechanical ventilation. Yet, selective
intubation and mechanical ventilation may be thed.
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pneumothorax or infections.2
We report here, a case of a 13-year old girl with
PAP, which was diagnosed accidentally. She was
successfully treated with TLL using flexible fiber-
optic bronchoscope (FFB), under a local anesthesia,
without complications. She was found free of
symptoms one-year after treatment.Figure 2 The characteristic ‘‘milky’’ appearance of BAL
fluid.Case report
A 13-year-old girl, was referred to our Hospital
because of a cranial trauma, which took place at
school. She was without loss of consciousness. Prior
to this incident she was given a 7-day course of oral
clarithromycin for a low respiratory tract infection.
Only an easy fatigue during exercise was present,
for which she had never consulted a physician.
On admission, the clinical examination was
negative. Although her routine chest X-ray showed
diffused bilateral interstitial and alveolar infil-
trates predominantly basal and apical (Fig. 1A),
her pulmonary function tests showed no defect on
spirometry (FVC ¼ 104%, FEV1 ¼ 119% of predicted
values). Diffusion capacity for CO test was ham-
pered by poor patient compliance. Arterial blood
gas performed in room air, showed PO2 ¼ 75mmHg,
PCO2 ¼ 30mmHg and pH ¼ 7.43, with desaturation
during effort (PO2 ¼ 68mmHg). Routine blood tests
and the results of blood chemical analysis and urine
analysis were normal. Immunological and serologi-
cal tests for viruses (adenovirus, cytomegalovirus,
Ebstein Barr, Herpes simplex) plus chlamydia and
mycoplasma were all negative. Cultures of phar-
yngeal smear and sputum were sterile. Sweat test
and ophthalmological examination were also nor-
mal. Tuberculin test was negative. Erythrocytes
sedimentation rate was 5 at the first hour, and
C-reactive protein within the normal limits.Figure 1 (A) Chest X-ray showing diffused bilateral intersti
diffuse, bilateral alveolar infiltrates associated to ground-glaChest high-resolution computed tomography
(HRCT) showed diffuse, bilateral alveolar infil-
trates, ground-glass opacities associated with re-
ticulo-nodular pattern (Fig. 1B). These findings
were asymmetric. Fiberoptic bronchoscopy with
BAL showed a viscous, opalescent (‘‘milky’’) ap-
pearance fluid (Fig. 2). Transbronchial biopsies
(TBB) were taken from the right lower lobe
(Fig. 3). The BAL fluid showed a background of
amorphous, finely granular material, stained posi-
tively for PAS, and enlarged, vacuolated alveolar
macrophages. Cultures were sterile.
After confirmation of the PAP diagnosis, we
performed a TLL with FFB under local anesthesia,
oxygen supplementation and monitoring of oxygen
saturation. We used 500ml of normal saline,
warmed at 37 1C, for each lung introduced by
boluses of 50ml. We monitored the SaO2, under
oxygen supplementation and as soon as SaO2 fell
below 90%, we increased the O2 concentration. The
average time for our procedure was 35min. The
patient then was transferred to the Department oftial and alveolar infiltrates and (B) chest HRCT showing
ss opacities with no concrete distribution (crazy paving).
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Figure 3 PAS stain  200 of TBB. The alveoli are filed by
eosinophilic amorphous or finely granular material in
which cholesterol clefts are recognized. The alveolar
architecture is maintained.
Figure 4 Chest X-ray after total lung lavage with
regression of radiological abnormalities.
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37.8 1C was noted during the first 24 h after the
procedure. Her recovery was without clinical or
biological findings of infection. We observed clear
regression of radiological abnormalities, 20 days
after TLL (Fig. 4). One year after diagnosis, the
patient was still free of respiratory symptoms with
normal blood gases on exertion and there were no
indications for further lavage.Discussion
The prevalence of PAP in the general population is
estimated to be less than 1:200,000. The disease
occurs predominantly in adults with a median age,
at the time of diagnosis, of 39 years. Theprevalence of the disease is much lower in children.
Although, recently published reports suggest a
genetic deficiency which may lead to the surfactant
accumulation in the congenital forms of the
disease, PAP is secondary or idiopathic in the
majority of cases.1,2,4
Our young patient had an almost asymptomatic
presentation of PAP, without the classically de-
scribed cough, dyspnea, recurrent lung infections,
weight loss, clubbing, crackles and cyanosis.1–3
Only an easy fatigue during exercise was present. It
was also striking that the radiographic findings
were disproportionate to the symptoms. Radio-
graphic findings in children are sometimes more
homogenous in distribution than those described in
adults.5 The pattern found on HRCT in our case is
usually described in adults with PAP as ‘‘crazy
paving’’.6 The association of clinical and radiologi-
cal findings with BAL and TBB confirmed the
diagnosis in our patient.1,2
The gold standard of therapy is TLL.2 It has been
shown that the 5-year survival rate is significantly
better (P ¼ 0.04) in patients who underwent TLL
than those who did not (94% versus 85%).7 The
procedure is performed under a general anesthesia
with rigid bronchoscope, after selective intubation.
In a recent retrospective study of 231 cases of
young adults, TLL improved clinical, radiological
findings and patient’s quality of life.7 The mean
duration of clinical improvement has been reported
to be around 15 months.7 In children with idio-
pathic PAP, treated by TLL, the prognosis has been
described as good.8,9
Single lung lavage by FFB was also performed in
four adult patients with PAP, under a general
anesthesia and mechanical ventilation.10 However,
selective intubation and mechanical ventilation
may be the cause of severe complications such as
barotrauma, pneumothorax and infections.2 The
use of anesthetics may be a risk factor, especially
for hemodynamic changes during the procedure. In
children, persistent hypoxemia after therapeutic
bronchoscopy under a general anesthesia, has also
been described.
Successful treatment of PAP with multiple seg-
mental or lobar lavage by fibreoptic bronchoscopy
without general anesthesia has also been reported
in adults.11 However, the yield by this method is
small and the volumes of lavage fluid limited.11
Hence, multiple lavages are required and this
makes the procedure less tolerable than whole
lung lavage.2,11 As far as we know, no TLL has been
reported by awake fiberoptic bronchoscopy under
local anesthesia only. The originality in our case is
that TLL was performed under awake FFB with
success and without complications, in a 13-year-old
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bation and mechanical ventilation.
The administration of recombinant GM-SCF in
patients with acquired idiopathic PAP12 is contro-
versial, since some of the cases will resolve
spontaneously and the bone marrow potential
may be affected due to a long-term GM-SCF
administration.1,7
Our case illustrates the importance of an
individual therapeutic approach for this disease.
Successful TLL by awake FFB is feasible with no
complications in our 13-year-old patient with
acquired PAP. This is the first report of a PAP in
children treated by awake bronchoscopy under
local anesthesia. It shows the spectrum of ther-
apeutic applications of FFB.References
1. Trapnell BC, Whitsett JA, Nakata JA. Pulmonary alveolar
proteinosis. N Engl J Med 2003;349:2527–39.
2. Shah PL, Hansell D, Lawson PR, Reid KB, Morgan C.
Pulmonary alveolar proteinosis: clinical aspects and current
concepts on pathogenesis. Thorax 2000;55:67–77.
3. Rosen SH, Castleman B, Liebow AA. Pulmonary alveolar
proteinosis. N Engl J Med 1958;258:1123–42.4. Crocker HL, Pfitzner J, Doyle IR, Hague WM, Smith BJ, Ruffin
RE. Pulmonary alveolar proteinosis: two contrasting cases.
Eur Respir J 2000;15:426–9.
5. Albafouille V, Sayegh N, De Coudenhove S, Scheinmann P, De
Blic J, Mamou-Mani T, et al. CT scan patterns of pulmonary
alveolar proteinosis in children. Pediatr Radiol
1999;29:147–52.
6. Johkoh T, Itoh H, Muller NL, Ichikado K, Nakamura H, Ikezoe
J, et al. Crazy-paving appearance at thin-section CT:
spectrum of disease and pathologic findings. Radiology
1999;211:155–60.
7. Seymour JF, Presneill JJ. Pulmonary alveolar proteinosis:
progress in the first 44 years. Am J Respir Crit Care Med
2002;166:215–35.
8. Mahut B, Delacourt C, Scheinmann P, de Blic J, Mani TM,
Fournet JC, et al. Pulmonary alveolar proteinosis: experi-
ence with eight pediatric cases and a review. Pediatrics
1996;97:117–22.
9. Dinwiddle R. Treatment of interstitial lung disease in
children. Paediatr Respir Rev 2004;5:108–15.
10. Chesnutt MS, Nuckton TJ, Golden J, Folkesson HG, Matthay
MA. Rapid alveolar epithelial fluid clearance following lung
lavage in pulmonary alveolar proteinosis. Chest
2001;120:271–4.
11. Brach BB, Harrel JH, Moser KM. Alveolar proteinosis: lobar
lavage by fibreoptic bronchoscope technique. Chest
1980;69:224–5.
12. Schoch OD, Schanz U, Koller M, Nakata K, Seymour JF, Russi
EW, et al. BAL findings in a patient with pulmonary alveolar
proteinosis successfully treated with GM-CSF. Thorax
2002;57:277–80.
